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Abstract
Background: More and more experiments have shown that transcription and mRNA processing are not two independent
events but are tightly coupled to each other. Both promoter and transcription rate were found to influence alternative
splicing. More than half of human genes have alternative promoters, but it is still not clear why there are so many alternative
promoters and what their biological roles are.
Methodology/Principal Findings: In this study, we explored whether there is a functional correlation between alternative
promoters and alternative splicing by a genome-wide analysis of human and mouse genes. We constructed a large data set
of genes with alternative promoter and alternative splicing annotations. By analyzing these genes, we showed that genes
with alternative promoters tended to demonstrate alternative splicing compare to genes with single promoter, and, genes
with more alternative promoters tend to have more alternative splicing variants. Furthermore, transcripts from different
alternative promoters tended to splice differently.
Conclusions/Significance: Thus at the genomic level, alternative promoters are positively correlated with alternative
splicing.
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Introduction
Alternative splicing (AS) is a common post-transcriptional
process used by eukaryotic organisms to generate multiple
transcript variants from a single gene [1]. It is known that
approximately 60% of human genes are susceptible to AS [2,3].
Substantial evidence has indicated that AS plays an important role
in development, differentiation, and cancer [4–6], and misregula-
tion of AS is associated with human disease [7]. AS is also
considered as the major mechanism expanding protein diversity.
Most research on the regulation of AS has focused on
identifying sequence features (cis-acting elements) within the
mRNA that either enhance or silence the usage of adjacent splice
sites, and the proteins that bind to these sequences (trans-acting
elements) to define global splicing patterns. The known cis-acting
sequence elements in exons and introns that are important for
promoting splice-site recognition include exonic splicing enhancers
(ESEs), intronic splicing enhancers (ISEs), exonic splicing silencers
(ESSs), and intronic splicing silencers (ISSs) [8]. These sequences
tend to be short (typically ,5–10 nt in length) and consist of
relatively degenerate consensus sequences that are recognized by
trans-acting splicing factors, such as serine/arginine-rich domain
proteins (SR proteins) and nuclear ribonucleoprotein proteins
(hnRNPs), which can regulate the use of a splice site [8–10].
Besides the cis-acting and trans-acting factors identified above, a
number of studies have revealed that promoters may also be
involved in the regulation of pre-mRNA splicing [11]. When an
alternatively spliced exon (EDA) from the fibronectin 1 gene was
chimerized with alpha 1 hemoglobin gene and formed a globin-
fibronectin gene, the ratio of mRNA that included or excluded this
alternative exon was shown to be strongly influenced by the
promoter used to drive transcription [12,13]. The cytomegalovirus
promoter resulted in an EDA inclusion several times more than
that of alpha-globin [12,13]. Similar effects of promoters on AS
have also been found in other genes [14–16].
It was revealed that more than half of human genes (at least
53%) have alternative promoters (APs) [17]. A number of studies
indicated that APs of a gene have different tissue specificity
[18,19], developmental activity [20] and/or transcription activity
[21], and generate transcripts with different 59 untranslated
regions (59UTR) or open reading frames (ORF) [22]. But it is still
not clear why there are so many APs in genome. Different APs
may be different in promoter elements such as CpG islands [17].
Thus it is possible that genes with APs have the ability to generate
AS variants. There are also several cases suggesting that APs are
linked to AS [23,24], but whether this happens only in
experimental conditions or universally exist at the genomic level
in physiological condition is not known.
PLoS ONE | www.plosone.org 1 June 2008 | Volume 3 | Issue 6 | e2377In this paper, we have extracted and combined APs and AS
annotations from several databases and demonstrated that genes
with APs tended to generate AS variants. Additionally, the number
of APs was positively correlated with the number of AS variants
within the genes with APs and AS variants. Comparing the mouse
full-length cDNA sequences further demonstrated that two
transcripts transcribed by different APs tended to splice differently.
We concluded that at the genomic level, APs are positive
correlated with AS.
Materials and Methods
Identification AS and non-AS genes
AS annotations of human and mouse genes were obtained from
AltSplice database (http://www.ebi.ac.uk/asd/) and Ecgene
(http://genome.ewha.ac.kr/ECgene/). The splice annotation data
in AltSplice database was generated by comparison of EST/
mRNA mapping data. Transcripts that have the same exon
structures were grouped into ‘class’. In principle, different ‘classes’
represented different splice patterns. Ecgene used an algorithm
and EST/mRNA resource which was different from AltSplice.
The AS annotations we used in this study were based on the
annotations from AltSplice and Ecgene databases. 16560 human
and 15986 mouse annotated genes were extracted from the
AltSplice version 3 dataset. Another set of genes with AS
annotations were extracted from the Ecgene dataset. Ecgene IDs
were converted to Ensembl gene IDs, such that annotations in the
Ecgene dataset could be merged with that of the AltSplice dataset
(see below). We obtained 8644 human and 8670 mouse genes with
annotations of AS from Ecgene dataset.
Genes with AS variants identified in both AltSplice and Ecgene
datasets were defined as alternatively spliced genes. Genes with no
AS variants identified in both datasets were defined as non-
alternatively spliced genes.
Estimation of alternatively spliced variants
We used the ‘class’ number extracted from the AltSplice
database as the estimate of the number of AS variants. But there
were two situations we considered with caution. Firstly, there may
have been classes that did not overlap with one another. The
second was although two classes overlapped with each other, the
region of overlap may have had the same structure. The classes in
these two situations may not have represented a distinct splice
variant (see http://www.ebi.ac.uk/asd/altsplice/AltSplice-pipeline.
pdf). Thus, besides using ‘class’ number as the estimate of splice
variant number, we have also used a weighted method such that
a class was counted as 0.5 splice variant if it followed the above
two situations.
As an alternative to the AltSplice data, the number of splicing
variants in the Ecgene database was calculated using a graph-
theory based algorithm [25]. The exon and intron structure of a
gene were presented as a directed acyclic graph (DAG). Nodes and
edges correspond to exons and introns respectively and each
possible path in the DAG corresponded to a putative splice
variant. Then the EST and/or mRNA (from Unigene) supported
splice variants were searched. We only counted the splice variants
verified by at least one full-length clone as our estimate of AS for
the purpose of reliability.
Identifying alternative promoter numbers
AP annotations of human and mouse genes were extracted from
the dataset downloaded from Database of Transcriptional Start
Sites (DBTSS). Refseq IDs in the dataset were converted into
Ensembl gene IDs, so as to merge the AP annotations with AS
annotations by their common Ensembl gene IDs. Some genes (79
for human and 31 for mouse) were removed from our dataset due
to ambiguous mapping of their IDs. Finally we obtained 14036
and 13134 human and mouse gene datasets with AP annotations,
respectively.
Analysis of the relationship of AP and AS in full-length
cDNA data
Full-length cDNA genome mapping data was downloaded from
the FANTOM3 FTP site (http://fantom.gsc.riken.go.jp/down-
load.html). There were 102801 full-length enriched sequences
(including full-length and partial sequences) in the Fantom3
dataset. All of these sequences were mapped to the mouse genome
and annotated by the Fantom3 annotation system [26,27]. Any
transcript that mapped to the same chromosomal strand and
shared at least one exonic nucleotide overlap was grouped into a
transcription unit (TU) [27]. To ensure the sequences we used
were full-length protein-coding cDNA, we used several steps to
filter the original dataset:
a. Eliminate the sequences from other resources (e.g. GenBank)
and only the sequences from RIKEN and Refseq are kept in
out dataset.
b. Discard the sequences without putative 59UTR and 39UTR
annotations.
c. Remove the sequences that have no confirmed strand
annotations.
Finally, 26715 full-length cDNA mapping data were left. After
we eliminated the TUs with only one cDNA sequence, we finally
obtained 8807 TUs with at least two reliable full-length cDNA
sequences.
For each TU, all possible transcript combinations, or transcript
pairs (TPs), were collected. To investigate whether two transcripts
in a TP are alternatively spliced, an algorithm was developed.
Basically, given a TP, we compared the exon coordinates of one
member with those of the other member. An AS event was defined
by the exon coordinates comparison status. There were three
states of comparison between an exon and a transcript: falling
outside the coordinates of the transcript, overlapping with an exon
of the transcript, and completely falling inside an intronic region.
Exons with coordinates that fell outside of the transcripts were not
informative, thus we only considered the last two states in the
following analyses. For an internal exon, an AS event was
considered as either completely mapping within the intronic
region or overlapping with the exon but extending or truncating at
one or both ends. For a 59 or 39 terminal exon with overlapping
status, only extending or truncating at the interior end was
considered an AS event. For a 39 terminal exon, if it was mapped
completely to the intronic region of another transcript, an AS
event was considered. TPs with one or more AS events mentioned
above were considered alternatively spliced and grouped as AS-
TPs. There was another AS event, which was derived from a
situation in which the 59 terminal exon was completely mapped to
intronic region of another transcript. We treated this type of AS
event separately, and TPs with only this AS event were classified
into another TP group named C5T-TPs. The reason for this was
that our intention was to assess the hypothesis that APs have
regulatory effects on AS, whereas this type of AS event is definitely
correlated with TSS, and thus not informative. TPs without any of
the AS events were grouped as Non-AS-TPs (Figure 1).
Two transcripts with a TSS distance interval larger than 500 bp
were considered to be transcribed from different APs. The
Promoters Influence Splicing
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transcripts were transcribed from different promoters [17].
All the statistic analyses were conducted by R.
Results
Genes with APs tend to show splicing
The idea that transcription and pre-mRNA processing are
independent events has dominated our conception of pre-mRNA
processing for a long time. But recently, evidence has indicated
that transcription and splicing are tightly coupled to each other
[28]. Transcripts from different promoters lead to changes in exon
inclusion levels or AS pattern [12,13,15]. Possible mechanisms
include the recruitment of factors with dual functions in
transcription and splicing, and control of RNA polymerase II
elongation [28].
52% of human and 27.8% of mouse genes have APs in the
DBTSS. APs in the same gene may contain different promoter
elements such as CpG islands [17]. Thus genes with APs possibly
generate AS variants. There is also experimental evidence
suggesting that APs are linked to AS [23,29]. It is highly intriguing
to examine whether genes with APs tend to demonstrate AS at the
genomic level.
We obtained 7909 human genes and 7602 mouse genes with AS
and AP annotations from the AlterSplice and Ecgene datasets.
6728 out of 7909 human genes and 5698 out of 7602 mouse genes
were identified as alternatively spliced genes (Table 1: Alterna-
tively spliced genes) which have AS variants in both databases (see
Material and methods). The remaining 1181 human genes and
1904 mouse genes (Table 1: Others) were those that have no AS
variants in one or both of the databases.
We then compared the percentages of alternatively spliced
genes in genes with APs (multiple-promoter genes) or genes
without APs (single-promoter genes). Our results showed that
multiple-promoter genes were notably enriched with alternatively
spliced genes. As shown in Table 1, among multiple-promoter
genes, we observed 91.9% of human and 87.5% of mouse genes
were alternatively spliced genes. However, among single-promoter
genes, we only observed 76.5% of human and 69.7% of mouse
genes generating AS variants. Our results indicated that compared
with single-promoter genes, multiple-promoter genes tended to
demonstrate AS. However, more than half of human and mouse
single-promoter genes also had AS variants. This indicated that
APs may be not indispensable for the generation of AS. Another
possibility was that the single-promoter genes were indeed
multiple-promoter genes, but mis-annotated as single-promoter
genes due to lack of full-length cDNA data.
Conversely, do genes that have no AS variants tend to have
single promoters? We have also identified 250 human and 508
mouse non-alternatively spliced genes (see Materials and Methods
for the definition). As expected, among the non-alternatively
spliced genes, we observed that 215 human and 479 mouse genes
have single promoters (Table 2), which were significantly higher
than as expected due to chance alone (p,0.001, Hyper-geometric
Test).
Positive relationship between the number of APs and the
number of AS variants
Our above results suggest that genes with APs are more likely to
demonstrate AS. We then further examined whether there is a
positive relationship between the number of AP and the number of
AS variants among the multiple-promoter genes with AS variants
(MPAS genes). We first classified human and mouse MPAS genes
into three groups based on the AP numbers (2,3, 4,5, 6,), and
then calculated and compared the mean number of AS variants
among the genes in each group.
As shown in Figure 2, human and mouse MPAS genes were
classified into three groups according to the AP numbers (with a
bin of 2,3, 4,5, 6,). The mean number of AS variants for
human genes with 2,3 promoters and 4,5 promoters were 6.98
and 9.28, respectively. However the mean number of AS variants
for genes with 6, promoters was 11.85,nearly doubled the genes
with 2,3 promoters (p,0.001, Wilcoxon Test) (Figure 2A).
Figure 1. Classification of transcript pairs (TPs) based on the
AS events derived from exon coordinates comparison. In all
three examples of full-length cDNA comparisons, constitutive exons are
shown in gray, alternatively spliced exons are shown in red, and introns
are represented by solid lines. The first exon and last exon in each
example represents the 59 most exons and the 39 most exons of full-
length cDNA, respectively. Non-AS-TPs: TPs with members that are not
alternatively spliced. As shown in the figure, differences in exterior part
of the 59 most or 39 most exons are not considered an AS event. AS-TPs:
TPs with members that are alternatively spliced. Any difference in the
interior exon or the interior part of the 59 most or 39 most exons is
considered an AS event. The figure shows an exon skipping event, used
to represent other AS events including exon skipping, alternative 59
splice sites, alternative 39 splice sites, intron retention, and mutually
exclusive. C5T-TPs: TPs were classified as C5T-TPs in cases in which the
59 most exon of one transcript is completely mapped to the intronic
region of another transcript, and there is no other type of AS event.
doi:10.1371/journal.pone.0002377.g001
Table 1. The percentage of alternatively spliced genes among groups of single-promoter genes and multiple-promoter genes.
Human Mouse
Alternatively spliced genes (Percentage) Others (Percentage) Alternatively spliced genes (Percentage) Others (Percentage)
Single-promoter genes 2692 (76.5%) 827 (23.5%) 3744 (69.7%) 1625 (30.3%)
Multiple-promoter genes 4036 (91.9%) 354 (8.1%) 1954 (87.5%) 279 (12.5%)
Note. The percentage alternatively spliced genes is different between groups of single-promoter genes and of multiple-promoter genes (P,0.001 by x
2 Test).
Alternatively spliced genes: genes that have AS variants in both AlterSplice and Ecgene datasets. Others: genes that have no AS variants in one or both of the datasets.
doi:10.1371/journal.pone.0002377.t001
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The mean number of AS variants of mouse genes was 5.76 for
those with 2,3 promoters, 7.22 for those with 4,5 promoters,
however the mean number of AS variants increased to 10.16 for
genes with 6, promoters (p,0.001 for genes with 2,3 promoters
versus genes with 4,5 promoters; p,0.001 for genes with 4,5
promoters versus those with 6, promoters; Wilcoxon Test).
Overall, the above results suggest that at the genomic level, a
positive correlation exists between the number of APs and the
number of AS variants among MPAS genes. Genes with more APs
tend to generate more AS variants.
We used ‘class’ numbers extracted from AltSplic to represent
the AS variant numbers in the above analysis. However, ‘class’
numbers may not represent AS numbers in the following two
situations. In one case, a ‘class’ which does not overlap with
another ‘class’ may represent different regions of the gene. The
second is the case in which the overlapped region of the two ‘classes’
has the same exon structure (see http://www.ebi.ac.uk/asd/
altsplice/AltSplice-pipeline.pdf). We recalculated the number AS
variants using a new method, which gave these ‘classes’ a smaller
weight. That is, if two ‘classes’ have no overlap or the overlapped
region with the same exon structure, we counted each ‘class’ as 0.5
AS variant. The analysis using the new AS variant number revealed
that although the mean AS variants for each AP group was less than
those of our previous analysis, genes with more APs always had a
higher number of mean AS variants (Supplementary Figure S1).
We have found that the number of APs was also positively
correlated with the number of exon per gene (Supplementary Figure
S2). To verify whether the correlation influenced our results, we
grouped genes with similar exon numbers, and examined the
correlation of number of APs and number of AS variants in each
groups. Our results indicated that the positive correlation between
AP and AS presented over all the intervals of exon count
Table 2. The number of genes with single promoter among
non-alternatively spliced genes.
All Genes with single promoter P-values
Human 250 215 1.509555e-44
Mouse 508 479 3.023425e-44
Note. The vast majority of the non-alternatively spliced genes have a single
promoter. All: the number of all the non-alternatively spliced genes. Genes with
single promoter: the number of genes with single promoter among non-
alternatively spliced genes. P-value: the probability that an observation (non-
alternatively spliced genes with single promoter) is made by chance, is
calculated using the cumulative Hyper-geometric Distribution.
doi:10.1371/journal.pone.0002377.t002
Figure 2. Genes with more APs tend to generate more AS variants. Number of AS variants was calculated based on AlterSplice dataset.’’
Genes with more APs showed an increased mean AS variants in human (A) and mouse (B) genes with APs and AS variants (MPAS genes). Error bar,
95% confidence intervals obtained from nonparametric bootstrapping.
doi:10.1371/journal.pone.0002377.g002
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PLoS ONE | www.plosone.org 4 June 2008 | Volume 3 | Issue 6 | e2377(Supplementary Figure S3). Since numbers of APs have no
correlation with EST coverage per exon (Supplementary Figure
S4), we can also eliminate the possibility that our results were due to
the correlation of APs with the number of covered ESTs per exon.
We repeated our analysis using the dataset extracted from
Ecgene database, which use EST/mRNA resource and algorithm
different from AltSplice database. The results were essentially
identical to those from the AltSplice dataset (Figure 3).
Overall, this part of analyses revealed that among MPAS genes,
the number of APs is positively correlated with the number of AS
forms at the genomic level, which is consistent with experimental
results showing that promoter structure can affect AS [28].
Transcripts from different alternative promoters tend to
splice differently
About 103000 entirely sequenced cDNA clones in the
FANTOM3 database from the RIKEN mouse Gene Encyclope-
dia project facilitated the direct testing of whether transcripts from
different APs tended to splice differently for a given gene. In the
FANTOM3 data set, transcripts from several sources (e.g.
GenBank and Ensembl) have been collected and mapped to the
mouse genome. Sequences that contain common core genetic
information (in some cases, a protein-coding region) were clustered
into TUs [27]. We used several eliminating steps to guarantee the
sequences we used were indeed full-length cDNA (see Materials
and Methods). Finally, we obtained 26715 full-length cDNAs
belonging to 8807 TUs.
Two transcripts with same TSS were considered as the same
transcript and TPs composed of such transcripts were discarded.
After filtering out 12750 TPs composed of same transcripts, 51578
pairs composed of putatively different transcripts remained.
To determine whether two transcripts of a TP were transcribed
from different APs, we measured and compared their TSS
distance. TPs with a TSS distance larger than 500 bp were
considered to be transcribed from different APs, and conversely
TPs with a TSS distance smaller than 500 bp were considered to
be transcribed from the same AP. This finally yielded 5927 TPs
which might be transcribed from different APs (‘‘TPs with
different APs’’) and 45651 TPs which might be transcribed from
the same APs (‘‘TPs with same APs’’).
Whether members of a TP were alternatively spliced was
determined by comparison of the exon genomic coordinates of each
transcript. TPs were divided into three groupsbased on theASevent
derived from the exon coordinate comparison (see Materials and
Methods). TPs were grouped as Non-AS-TPs if transcripts were not
alternativelyspliced.OthersTPswithalternativelysplicedtranscripts
were either grouped as AS-TPs or C5T-TPs (Figure 1).
To test whether transcripts transcribed from different APs tended
to be alternatively spliced, we examined the percentage distributions
of AS-TPs and Non-AS-TPs in the ‘‘TPs with different APs’’ and
‘‘TPswithsameAPs’’groups,respectively.AsindicatedinFigure4A,
among ‘‘TPs with different APs’’, the percentage of AS-TPs was
approximately 57.8% (3425/5927), while that of Non-AS-TPs was
approximately 25.8% (1530/5927). The percentage of AS-TPs was
double that of Non-AS-TPs. Thus, two transcripts tended to be
alternatively spliced if they were transcribed from different APs.
Since ‘‘AS-TPs’’ mentioned above did not include ‘‘C5T-TPs’’
(representing approximately 16.4% all ‘‘TPs with different Aps’’),
our result implied that the positive correlation between AP and AS
might be resulted from regulatory effect of AP on AS.
By analyzing the ‘‘TPs with same APs’’, we found a reverse
distribution in the frequencies of AS-TPs and Non-AS-TPs
compared to ‘‘TPs with different APs’’. As shown in Figure 4B,
the majority of TPs were Non-AS-TP (70%, 32035/45651),
compared to AS_TPs (27.7%, 12631/45651). Of the remainder,
2.2% were C5T-APs. The data suggested that transcripts with the
same APs are not likely alternatively spliced, consistent with the
analysis of ‘‘TP with different APs’’.
Figure 3. Positive relationship between the number of APs and the number of AS variants calculated using Ecgene dataset. Genes
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in ‘‘TPs with same APs’’ compared with ‘‘TPs with different APs’’
was statistically significant (P,0.001 for both comparison, x
2 Test).
We also divided the TPs into multiple groups according to the
TSS distance interval, and recalculated the percentages of ‘‘AS-
TPs’’, ‘‘Non-AS-TPs’’ and ‘‘C5T-TPs’’ in each group. We observed
that the distribution bias towards ‘‘AS-TPs’’ in groups with TSS
distance spans of ‘‘300,500 bp’’, ‘‘500,1000 bp’’ and ‘‘1000,bp’’
(see Supplementary Figure S5). This result indicated that splice
patterns tended to be different if two transcripts have TSS distances
larger than 300 bp. Thus, our above result was independent of the
criterion (500 bp interval) we used to divide the TPs.
In total, our analyses revealed that transcripts transcribed from
different APs tended to be alternatively spliced and thus provided
additional support for the relationship between APs and AS.
Discussion
In this study, we conducted genome-wide studies of the
relationship between APs and AS using the data collected from
publicly available resources. Our results revealed that genes with
APs are more likely to generate AS variants than genes with a
single promoter. Interestingly, genes that do not undergo AS were
significantly enriched within single-promoter genes. Thus, it seems
that the AS variants of a gene are highly correlated with the AP
number it possesses. We have found that the number of AP was
positively correlated with the number of AS variants in genes with
APs generating AS variants. By comparing full-length cDNA
mapping data in each TU, we have also found direct evidence to
show that transcripts transcribed from different APs tended to be
alternatively spliced.
In our analysis, parts of AS annotations were extracted from
AltSplice dataset, in which transcripts with different splicing
pattern were grouped into separate ‘classes’. However, in some
situations, the different ‘classes’ may not have represented different
AS variants, but different regions of the genes. Thus, using the
‘classes’ number as the estimate of the number of AS variants may
overestimate the genuine number of AS variants. We have used a
weighted method to reduce such bias in case ‘classes’ did not
represent genuine AS variants. Our results showed, although the
mean number of AS variants was reduced relative to the former
method, the positive relationship was still present across all ranges
of APs. Using the AS variant numbers estimated from the Ecgene
dataset also supported the positive relationship between the
number of APs and the number of AS variants.
Our finding is in consistent with the recent finding that
transcription is involved inmRNA processing. The most supportive
evidence showing that transcription and AS are coupled with each
other is that the use of different promoters resulted in drastic
changes in an alternatively spliced exon inclusion [12,13]. This
promoter-dependent AS pattern has also been found in other
experiments [14–16]. Several splicing proteins have been shown to
interact directly with the C-terminal domain (CTD) of Pol II [30–
32]. A recruitment model was raised to describe these results
[28,33]. Binding of splicing factors to the CTD increases their local
concentration, thereby promoting otherwise weak interactions
between the splicing factors and the pre-mRNA.
More and more studies have suggested that RNA polymerase II
(Pol II) elongation can affect the frequency of exon inclusion. Low
Pol II elongation rates would favor the inclusion of alternative
exons, whereas a high elongation rate would favor exclusion of
these exons [34–36]. These results were described by a kinetic
model [22,28]. This model states that slowing Pol II transcrip-
tional elongation allows spliceosomal components to bind to the
weak exon without having to compete with a subsequent strong
exon, therefore favoring the recognition and inclusion of the weak
exon. Faster elongation results in skipping of the weak exons
because the subsequent strong exons compete with the spliceo-
somal components for the weak exons. Our findings that APs are
positively correlated with AS was consistent with the finding that
promoter structure affects AS and the above two models. Different
APs could recruit promoter specific transcription co-activator and
splicing proteins, which would in turn influence the Pol II
elongation rate. Both the specificity of the splicing proteins and the
Pol II elongation rates lead to different splicing. Other factors,
such as difference in 59UTRs of transcripts from different APs,
may also contribute to the AS.
Figure 4. Percentage distributions of ‘‘AS-TPs’’, ‘‘Non-AS-TPs’’ and ‘‘C5T-TPs’’ across ‘‘TPs with different APs’’ and ‘‘TPs with same
APs’’. (A) The distributions of TP percentages in ‘‘TPs with different APs’’ group. The percentage of AS-TP (57.8%) is two times larger than that of the
Non-AS-TPs (25.8%). The proportion of C5T-TPs is 16.4%. (B) The distribution of TP percentages in ‘‘TPs with same APs’’. The percentage of Non-AS-
TPs (70%) is notably larger than that of AS-TPs (27.7%). The remaining 2.2% belongs to C5T-TPs.
doi:10.1371/journal.pone.0002377.g004
Promoters Influence Splicing
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in different tissues. Indeed, we found genes that with APs are
expressed more broadly in tissues than those with single promoters
(SupplementaryFigure S6).ThustranscriptsfromdifferentAPs have
the opportunity to present in different tissue environments and are
regulated by tissue specific splicing factors and other trans-acting
factors that are involved in AS. This might be one reason that in
genomic level APs are positive correlated with AS. Correspondingly,
beneficial alternative splicing might in turn promote the fix of an
alternative promoter. Therefore, as a result of co-evolution of APs
and AS, genes with more APs tend to have more AS variants.
AS is an important mechanism by which genes obtain function
diversity. Different promoters respond to different environments,
and regulate factors to function with appropriate splicing variants.
The evolutionary conserved positive correlation between APs and
AS probably facilitates quick adaptation of a species to a changed
environment.
Supporting Information
Figure S1 Positive relationship between the number of APs and
the numberofASvariantscalculated bya weighted method inAPAS
genes. (A) The mean number of AS variants for each AP group of
human APAS genes. The number of AS variants was calculated by a
weighted method (see Materials and Methods). Although the mean
AS variants were slightly lower than those calculated with an un-
weighted method (Figure 2), the positive relationship between the
number of AS variants and the number of APsremained. Genes with
more APs showed an increased mean AS variant. Error bar, 95%
confidence intervals obtained from nonparametric bootstrapping. (B)
The mean number of AS variants for each AP group of mouseAPAS
genes. The number of AS variants was calculated by a weighted
method (see Material and Methods). Similar to what is observed in
human genes, genes with more APs had an increased mean number
of AS variants. Error bar, 95% confidence intervals obtained from
nonparametric bootstrapping.
Found at: doi:10.1371/journal.pone.0002377.s001 (0.29 MB TIF)
Figure S2 Number of APs is positively correlated with number
of exons per gene. Genes with more APs have notably more exons
in human (A) and mouse (B). The gene number information was
extracted from AltSplice-rel3.splice-patterns.txt in the AltSplice
database. Spearman ranked correlation coefficients R=0.27 for
human genes, and R=0.20 for mouse genes.
Found at: doi:10.1371/journal.pone.0002377.s002 (0.34 MB TIF)
Figure S3 The influence of gene exon number on the
correlation between alternative promoter number and alternative
splicing number. In order to verify that our results are not due to
the correlation of AP with the number of exons, we examined the
correlation for specific intervals of exon count (2,3 exons, 4,5
exons, 6,7exons, 8,exons). As shown in figure below, positive
correlations were preserved across all the ranges for both human
(A) and mouse genes (B).
Found at: doi:10.1371/journal.pone.0002377.s003 (0.39 MB TIF)
Figure S4 AP number has no correlation with EST coverage per
exon. The number of APs is independent of the number of transcripts
per exon for human genes (A) and mouse genes (B), respectively. The
number of transcripts covering a given gene was extracted from the
AltSplice database. Spearman ranked correlation coefficients
R=20.022 for human gene and R=20.036 for mouse genes.
Found at: doi:10.1371/journal.pone.0002377.s004 (0.32 MB TIF)
Figure S5 Percentage distributions of ‘‘AS-TPs’’, ‘‘Non-AS-
TPs’’ and ‘‘C5T-TPs’’ across different TSS distance intervals.’’
The intervals of TSS distance used to plot the figures are: 0,50 bp
(A), 50,150 bp (B), 150,300 bp (C), 300,500 bp (D), 500,1000
bp (E), 1000,bp (F). The figures show that the distribution bias
toward ‘‘Non-AS-TPs’’ is preserved across all spans in which TSS
distances are ,300 bp (A, B and C), whereas distribution bias
towards ‘‘AS-TPs’’ can be observed across all other spans in which
TSS distances are .300 bp (D, E and F).
Found at: doi:10.1371/journal.pone.0002377.s005 (0.66 MB TIF)
Figure S6 Multiple-promoter genes tend to be expressed more
broadly than those with single promoters. Box-plot of the number
of tissues for all genes (All), single-promoter genes (Single-
promoter) and multiple-promoter genes (Multiple-promoter).The
thick black line indicates the median tissue number for each gene
category. The median number of tissues for multiple-promoter
genes (13) is statistically larger than that for the single-promoter
genes (7) (Wilcoxon Test, p,0.001). Microarray gene expression
data for 79 human tissues produced by Su et al., 2004 was
downloaded from Gene Expression Omnibus (GEO) (http://
www.ncbi.nlm.nih.gov/geo) and processed using the Bioconductor
affy package (http://www.bioconductor.org/).
Found at: doi:10.1371/journal.pone.0002377.s006 (0.22 MB TIF)
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